Schedule 13G ownership disclosure

CELLECTAR BIOSCIENCES INC

Common stock, par value $0.00001 · CUSIP: 15117F807

Event date: 2024-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nantahala Capital Management, LLC

    Shares: 3,677,739.00 · Class: 9.9900%

  • Wilmot B. Harkey

    Shares: 3,677,739.00 · Class: 9.9900%

  • Daniel Mack

    Shares: 3,677,739.00 · Class: 9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-119186
Form type
SCHEDULE 13G/A
Filer
Cellectar Biosciences, Inc.
CIK
CIK 1279704
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub